Actuate Therapeutics, Inc. (ACTU) income statement
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.23+0.01 (+5.38%)
Close on Nov 20, 2026Market cap $5.41MP/E –Yield –
Actuate Therapeutics, Inc. financial ratios
See a number that looks wrong?